The Human Organoids Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of human organoids has seen swift expansion in the past few years. It increased from $1.47 billion in 2024 to $1.71 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 16.8%.
The Human Organoids Global Market is predicted to reach a market size of $3.15 billion in 2029, with a compound annual growth rate (CAGR) of 16.5%.
Download Your Free Sample of the 2025 Human Organoids Market Report and Uncover Key Trends Now!The key drivers in the Human Organoids market are:
• Growing demand for organoid-based disease modeling
• Rising investment in biotech research
• Expansion of organoids use in drug screening and toxicology studies
• Increasing interest in precision medicine
The human organoids market covered in this report is segmented –
1) By Type: Brain Organoids, Heart Organoids, Intestinal Organoids, Kidney Organoids, Liver Organoids, Lung Organoids, Pancreatic Organoids
2) By Technology: 3D Bioprinting, Cell Culture Technology, Hydrogels And Scaffold-Based Technology, Magnetic Levitation
3) By Application: Drug Discovery, Infectious Disease Research, Neurology Studies, Oncology Research, Personalized Medicine, Regenerative Medicine
4) By End User: Pharma And Biotech Companies, Contract Research Organizations, Academic And Research Institutes
The key trends in the Human Organoids market are:
• Integration with artificial intelligence is becoming a notable trend in the human organoids market.
• There is an emerging trend of developing patient-specific organoids.
• The application of organoids in gene therapy is an emerging trend.
• Advancements in organoid bioprinting and 3D cell culture technology are significantly shaping the market's future.
Major companies in the Human Organoids market are:
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd.
• Corning Incorporated
• Bio-Techne Corporation
• Organovo Holdings Inc.
• Emulate Inc.
• MIMETAS B.V.
• Cellink AB
• InSphero AG
• Kerafast Inc.
• DefiniGEN Limited
• Visikol Inc.
• CN Bio Innovations Limited
• Cannex Scientific Inc.
• HeartBeat.bio AG
• Kirkstall Ltd.
• Cyprio Ltd.
• 3Dnamics Inc.
• BrainZell Ltd.
• AIVITA Biomedical Inc.
North America was the largest region in the human organoids market in 2024